You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Genentech, Inc. v. Amgen Inc. (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

Genentech, Inc. v. Amgen Inc. (D. Del. 2018)

Docket	⤷ Sign Up	Date Filed	2018-06-21
Court	District Court, D. Delaware	Date Terminated	2020-07-07
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	Plaintiff	Referred To	Sherry R. Fallon
Parties	AMGEN INC.
Patents	6,316,462; 7,449,184; 7,575,768; 8,512,983; 8,691,232; 9,714,293
Attorneys	Lisa J. Pirozzolo
Firms	Gibbons P.C.
Link to Docket	External link to docket

Biologic Drugs cited in Genentech, Inc. v. Amgen Inc.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Genentech, Inc. v. Amgen Inc. (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-07-02	10	Redacted Document	assignment of the ’122 patent. 62. U.S. Patent No. 7,449,184 (“the ’184 patent”), titled “Fixed…with Perjeta 60. U.S. Patent Nos. 7,501,122, 7,449,184, and 8,691,232 claim novel therapies… INFRINGEMENT OF U.S. PATENT NO. 7,449,184 190. Plaintiffs incorporate…: U.S. Patent No. 6,331,415, U.S. Patent No. 7,923,221, U.S. Patent No. 6,407,213, U.S. Patent No. 7,…, U.S. Patent No. 7,892,549, U.S. Patent No. 6,627,196, U.S. Patent No. 7,371,379, U.S. Patent No. 6,	External link to document
2019-06-14	256	Opinion - Memorandum Opinion	quot;the '066 patent"); 8,574,869 ("the '869 patent"); 8,512,983 ("the '…of terms set forth in U.S. Patent Nos. 7,993,834 ("the '834 patent"); 8,076,066 ("…#x27;983 patent"); and 7,390,660 ("the '660 patent"). D.I. 60; D.I. 121. 1 …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …clauses of both patents were added by Genentech in response to same objection by the patent examiner. Compare	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.